Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ophthalmology. 2013 Jan;120(1):e5-12. doi: 10.1016/j.ophtha.2012.07.008. Epub 2012 Sep 15.
To study the nature of retinal inflammatory response in rd10 mice, an animal model of retinitis pigmentosa (RP), and to investigate the effect of an antioxidant on retinal inflammation and photoreceptor apoptosis.
Experimental study.
This study included 42 untreated rd10 mice, 30 N-acetylcysteine (NAC)-treated rd10 mice, and 20 C57BL/6 mice as controls.
Real-time polymerase chain reaction (PCR) was performed to evaluate the expression levels of inflammatory factors (proinflammatory cytokines and chemokines) in rd10 mouse retinas. Rd10 mice were treated with an antioxidant NAC, and its effect on retinal inflammation and photoreceptor apoptosis were examined by immunohistochemistry.
Real-time PCR and immunohistochemistry.
We demonstrated sequential events involving increased expression of proinflammatory cytokines and chemokines, activation of microglia, and photoreceptor apoptosis during retinal degeneration of rd10 mice. Furthermore, antioxidant treatment with NAC prevented the photoreceptor cell death along with suppression of inflammatory factors and microglial activation.
Sustained chronic inflammatory reaction may contribute to the pathogenesis of retinal degeneration in rd10 mice, suggesting interventions for ocular inflammatory reaction using antioxidants as a potential treatment for patients with RP.
FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any of the materials discussed in this article.
研究 rd10 小鼠(一种视网膜色素变性模型)视网膜炎症反应的性质,并探讨抗氧化剂对视网膜炎症和光感受器细胞凋亡的影响。
实验研究。
本研究包括 42 只未经治疗的 rd10 小鼠、30 只 N-乙酰半胱氨酸(NAC)治疗的 rd10 小鼠和 20 只 C57BL/6 小鼠作为对照。
实时聚合酶链反应(PCR)用于评估 rd10 鼠视网膜中炎症因子(促炎细胞因子和趋化因子)的表达水平。用抗氧化剂 NAC 治疗 rd10 小鼠,通过免疫组织化学检测其对视网膜炎症和光感受器细胞凋亡的影响。
实时 PCR 和免疫组织化学。
我们发现在 rd10 小鼠视网膜变性过程中,促炎细胞因子和趋化因子的表达逐渐增加,小胶质细胞激活,光感受器细胞凋亡。此外,NAC 抗氧化治疗可预防光感受器细胞死亡,并抑制炎症因子和小胶质细胞激活。
持续的慢性炎症反应可能导致 rd10 小鼠视网膜变性的发病机制,提示使用抗氧化剂干预眼部炎症反应可能成为治疗视网膜色素变性患者的一种潜在方法。
作者在本文讨论的任何材料中均无专有或商业利益。